Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$0.35 - $0.72 $13,002 - $26,747
37,149 Added 15.37%
278,906 $102,000
Q4 2022

Feb 14, 2023

SELL
$0.32 - $8.27 $22,882 - $591,362
-71,507 Reduced 22.83%
241,757 $95,000
Q3 2022

Nov 14, 2022

SELL
$0.46 - $7.2 $151,784 - $2.38 Million
-329,967 Reduced 51.3%
313,264 $147,000
Q2 2022

Aug 15, 2022

BUY
$0.58 - $1.13 $363,657 - $708,504
626,995 Added 3861.76%
643,231 $376,000
Q1 2022

May 16, 2022

SELL
$0.73 - $1.81 $446,728 - $1.11 Million
-611,957 Reduced 97.42%
16,236 $16,000
Q4 2021

Feb 14, 2022

SELL
$1.66 - $2.64 $43,091 - $68,531
-25,959 Reduced 3.97%
628,193 $1.04 Million
Q3 2021

Nov 15, 2021

BUY
$2.58 - $3.36 $9,543 - $12,428
3,699 Added 0.57%
654,152 $1.76 Million
Q2 2021

Aug 16, 2021

SELL
$2.7 - $3.81 $1.65 Million - $2.33 Million
-610,568 Reduced 48.42%
650,453 $2.16 Million
Q1 2021

May 17, 2021

SELL
$3.02 - $5.16 $1.93 Million - $3.3 Million
-640,368 Reduced 33.68%
1,261,021 $4.19 Million
Q4 2020

Feb 16, 2021

BUY
$2.66 - $4.18 $1.2 Million - $1.89 Million
451,452 Added 31.14%
1,901,389 $7.2 Million
Q3 2020

Nov 16, 2020

BUY
$3.01 - $3.88 $1.98 Million - $2.55 Million
656,755 Added 82.8%
1,449,937 $4.57 Million
Q2 2020

Aug 14, 2020

BUY
$2.33 - $4.6 $1.78 Million - $3.51 Million
762,114 Added 2453.05%
793,182 $2.52 Million
Q1 2020

May 14, 2020

BUY
$1.91 - $4.52 $36,702 - $86,856
19,216 Added 162.13%
31,068 $83,000
Q4 2019

Feb 14, 2020

SELL
$2.57 - $4.08 $44,810 - $71,138
-17,436 Reduced 59.53%
11,852 $48,000
Q3 2019

Nov 14, 2019

BUY
$2.74 - $4.65 $80,249 - $136,189
29,288 New
29,288 $95,000
Q2 2018

Aug 14, 2018

SELL
$6.68 - $11.0 $674,873 - $1.11 Million
-101,029 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$10.14 - $12.38 $748,839 - $914,263
73,850 Added 271.72%
101,029 $1.11 Million
Q4 2017

Feb 14, 2018

BUY
$8.75 - $11.99 $237,816 - $325,876
27,179
27,179 $326,000

Others Institutions Holding MBIO

About MUSTANG BIO, INC.


  • Ticker MBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,222,000
  • Market Cap $24.2M
  • Description
  • Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...
More about MBIO
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.